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Abstract
Background: Displaced olecranon fractures after a simple fall are common in elderly patients. This patient group
often has multiple medical co-morbidities and low functional demands. Standard treatment for these fractures has
been operative fixation, using either wires or a plate. Recent case series suggest that such injuries can be managed
without surgery with good functional outcomes. There has been no published trial comparing operative to
non-operative treatment for displaced olecranon fractures.
This project aims to test for superiority of operative treatment versus non-operative treatment for displaced
olecranon fractures in the elderly, by comparing pain and function in the affected limb up to one year after
the injury.
Methods/Design: SOFIE is an international study with a multicentre pragmatic randomised controlled trial
design. The primary objective of the study is to compare a patient related outcome, the Disability of the Arm
Shoulder and Hand (DASH) Score, between patients treated operatively and non-operatively at twelve months.
Patients will be considered for the study if they are 75 years of age or older, medically fit for surgery, have an
isolated displaced olecranon fracture, and present within 14 days of injury. Eligible patients willing to participate
will be randomised either to operative fixation, with surgery using the preferred technique of the treating
orthopaedic surgeon (tension band wiring or plate fixation), or to non-operative treatment involving early range
of motion as tolerated.
Secondary outcome measures will include pain, active range of motion, elbow extension strength, and any
adverse events (infection, secondary interventions) at 3 and 12 months.
Discussion: The study will answer an important clinical question about the effectiveness of a commonly performed
orthopaedic procedure, and will guide future treatment for displaced olecranon fractures in the elderly.
Trial registration number: World Health Organisation Universal Trial Number (WHO UTN) - U111111574090.
Australian and New Zealand Clinical Trials Registry (ANZCTR) - ACTRN12614000588695.
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Background
The incidence of olecranon fractures in the adult popu-
lation is 11.5 per 100,000 per year. These fractures make
up 20 % of all proximal forearm fractures, and 8–10 %
of all elbow fractures. Recent studies have reported an
increasing incidence of olecranon fractures in the elderly
population [1, 2]. In this age group, they are predomin-
antly fragility fractures seen in patients with multiple
co-morbidities and low functional demands [3, 4].
The current standard treatment for displaced olecra-
non fractures, based on case series and tradition, is
operative fixation with either tension band wiring or
plate fixation [5–10]. Despite being commonly per-
formed, the results from studies investigating outcomes
and complications after operative fixation are conflict-
ing, especially in the elderly with osteoporotic bone.
Reported complications include those related to anaes-
thesia, as well as those specific to the surgical fixation
(wire migration, soft- tissue irritation, olecranon bur-
sitis, wire breakage, fracture displacement and the need
for a second operation for removal of hardware, with
rates as high as 70 %) [11–16].
Further to this high complication rate, there is recent
evidence from case series that non-operative manage-
ment of displaced olecranon fractures is a reasonable
option in elderly patients, with comparable outcomes
without the risk of anaesthetic and surgical complica-
tions [10, 17–19].
Despite extensive case series data, we are unaware of
any study directly comparing operative and non-operative
management of displaced olecranon fractures in the
elderly. The aim of our study is to perform a randomized
control trial testing for superiority of operative treatment
over non-operative treatment in restoring upper limb
function for displaced olecranon fractures in the elderly.
Methods and design
SOFIE is a prospective multicentre trial conducted at sites
in Australia and New Zealand. The study uses a pragmatic
randomised controlled trial design. The study flowchart is
provided in Fig. 1.
Ethics
SOFIE has been approved by the Hunter New England
Research Ethics and Governance Unit for all recruiting
sites. (HNEHREC Reference No: 13/10/16/4.04, NSW
HREC Reference No: HREC/13/HNE/405, These recruit-
ing sites in alphabetical order are Cairns Base Hospital;
Concord General Repatriation Hospital; Dubbo Base
Hospital; Frankston Hospital; Gosford Hospital; John
Hunter Hospital; Liverpool Hospital; Mackay Base
Hospital; Nambour General Hospital; Nepean Hospital;
Orange Base Hospital; Prince of Wales Hospital; Royal
Adelaide Hospital; Royal Brisbane Hospital; Royal North
Shore Hospital; Royal Prince Alfred Hospital; Ryde Hos-
pital; St George Hospital; Sutherland Hospital; Wellington
Hospital and Wyong Hospital.
The study was registered on the 03/06/2014 with
both the Australian and New Zealand Clinical Trials
Registry (ACTRN12614000588695) and the World
Health Organisation Universal Trial Registry (WHO
UTN - U111111574090).
Study population
Patients will be considered for the study if they are 75 years
or older, medically fit for surgery, have an isolated
displaced (more than 2 mm) olecranon fracture based on
standard anteroposterior (AP) and lateral radiographs,
and present within 14 days of injury to a participating
institution.
Patients will be excluded if they are unable to pro-
vide consent due to limited English proficiency or
cognitive impairment, have other fractures about the
elbow (coronoid, radial head, other ulna or distal hu-
merus fractures), an associated ligamentous injury, a
subluxed or dislocated elbow, a flipped fragment (prox-
imal fragment rotates 180° so that the rough trabecular
surface of the fracture is in direct contact with overly-
ing skin which can cause skin breakdown), or have an
open injury.
Recruitment
Recruitment of patients who meet study eligibility criteria
will involve an explanation of the rationale for the study.
This will be supplemented with a patient information sheet
(see Additional file 1). Patients willing to participate will be
asked to sign a consent form. Enrolled patients will then be
randomised to either operative or non-operative manage-
ment by using a central web-based randomisation service.
Basic demographic data will be collected for both groups
to look at independent variables including age, gender,
pre-injury difficulty using arm, comminution (yes/no),
diabetes (yes/no), smoking status (current smoker: yes/no)
and operation type (wiring or plating) (see Additional file
2). Limited de-identified demographic data (age, gender,
hand dominance, residential status) will also be collected
on patients who choose not to participate, or are ineligible
to participate due to inability to consent. This information
will be used to determine selection bias.
Randomisation
Consented patients will be randomised to either opera-
tive or non-operative management by using a central
web-based randomisation service. Randomisation will be
stratified by site.
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Interventions
The operative group will undergo surgical fixation by
the preferred technique of the treating surgeon (ten-
sion band wiring or plate fixation) in a manner
consistent with the usual care of the participating
institution. The post operative regime will include im-
mobilisation in a long-arm backslab for 2 weeks
followed by progressive range of motion as tolerated.
This pragmatic approach to surgical intervention more
accurately reflects current practice and improves study
feasibility and acceptance, and generalisability of the
results.
Non-operative treatment will consist of a sling as
needed and immediate progressive range of motion as
tolerated. A long-arm plaster splint may be applied for
the initial 2 weeks if needed for pain control, followed
by movement as tolerated. Any decision on referral for
physiotherapy will be left to the treating team for both
treatment groups.
Study investigators and participants will not be blinded
to treatment group. Blinded researchers, however, will
collect the primary outcome measure (DASH score at
12 months) via telephone. The statistician will also be
blinded to treatment group.
Outcome measures
Participants will be followed up at two weeks, three
months and twelve months post intervention. The
primary outcome will be the Disability of the Arm
Shoulder and Hand (DASH) Score at 12 months [20].
The DASH score is a widely used, validated outcome
tool used in studies of upper limb injuries and
surgery, and is a continuous score on a scale from 0 to
100 [21]. Secondary outcome measures collected at
3 months and 12 months will include DASH, EuroQol
Visual Analogue Score (EQ VAS), Pain Visual Analgoue
Scale (VAS), Mayo Elbow Performance Score (MEPS),
Fig. 1 Patient flow through study
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complications, elbow active range of motion, and elbow
extension strength.
Sample size calculation
The study will recruit a total of 65 patients with a mini-
mum of 26 in each group at 12 months. This is based on
having 95 % power to detect the minimum clinically
important difference (15 points) on the DASH score at a
significance level of 0.05 and it also allows for 20 % loss to
follow up [8, 9, 21].
Statistical analysis
A two-sided t test will be used to compare the two
independent groups. Adjustment for other variables will
not be necessary, as the technique of minimisation will
be used during randomisation, and randomisation will
be stratified by site. Intention to treat analysis will be
performed in the primary analysis. As-treated analysis will
be added as a secondary analysis. There will be no interim
analysis due to the low risk of adverse events compared
to usual care and adverse events will be monitored
and reported to the administering institution and project
manager. De-identified demographic information col-
lected from ineligible or non-consenting patients will be
used to understand selection bias in the study.
Monitoring and quality assurance
The adverse events to be recorded are infection (any
diagnosis of infection resulting in any treatment);
re-operation (including reason for reoperation); death
(including cause and likelihood of any casual link be-
tween treatment or study participation and death) and
implant failure (fracture or migration of implants).
Data will be collected by local site investigators and
submitted securely to the project manager at the admin-
istering institution. Data will be stored in locked filing
cabinets and password protected computers within the
administering institution. The coordinating and principal
investigators are responsible for the adherence to all eth-
ical committee rules and guidelines for the accuracy and
completeness of all forms, entries and informed consent.
Discussion
There are no prospective randomised controlled trials
comparing operative and non operative treatment for
displaced olecranon fractures in the elderly, with current
management based on case series and tradition alone.
The SOFIE trial will compare the management of
these fractures and in addition to examining a previously
unanswered clinical question about the effectiveness of a
commonly performed orthopaedic procedure, this study
will guide future treatment for this common injury,
potentially changing current practice.
Additional files
Additional file 1: SOFIE: Surgery for Olecranon Fractures In the
Elderly: a randomised controlled trial of operative versus non-operative
treatment. (DOC 49 kb)
Additional file 2: Patient Information Sheet. (DOCX 90 kb)
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